Gland Pharma posts 16% revenue growth in Q1 FY25
India emerging as world-class cost-effective healthcare destination and global pharma leader: Dr. Jitendra Singh
Aurobindo Pharma receives USFDA approval for Estradiol Vaginal Inserts USP, 10 mcg
SMS Pharmaceuticals reports Q1 FY25 consolidated PAT at Rs. 16.48 Cr
Cupid post Q1 FY25 profit at Rs. 8.25 Cr
Indraprastha Medical Corporation posts Q1 FY25 PAT at Rs. 44.77 Cr
Vijaya Diagnostic Centre reports Q1 FY25 consolidated PAT at Rs. 31.34 Cr
OneSource and BRL ink technology licensing agreement to deliver high-concentration biologics subcutaneously
Lupin receives USFDA approval for Prednisolone Acetate Ophthalmic Suspension USP
Lupin completes successful Phase 3 trials for Lucentis biosimilar
Pharmaceuticals and Consumer Health report higher sales (Fx & portfolio adj.) and lower earnings
Subscribe To Our Newsletter & Stay Updated
Chasing Consistency: Centralizing operations data is the key to optimizing chemicals plants
Implementing a digital transformation in chemical operations to maximize profitability
The complexity of compliance
The Sprint to the Summit: Unlocking Lab Efficiency through Digital Transformation
The guiding role of fluidized and spouted bed technologies in particle building processes